Ergomed Aktie kaufenswert? (Seite 8)
eröffnet am 01.12.16 16:57:13 von
neuester Beitrag 04.09.23 10:24:12 von
neuester Beitrag 04.09.23 10:24:12 von
Beiträge: 415
ID: 1.242.462
ID: 1.242.462
Aufrufe heute: 0
Gesamt: 19.693
Gesamt: 19.693
Aktive User: 0
ISIN: GB00BN7ZCY67 · WKN: A117XM · Symbol: 2EM
15,500
EUR
+1,04 %
+0,160 EUR
Letzter Kurs 10.11.23 Tradegate
Neuigkeiten
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,0000 | +33,33 | |
0,5500 | +22,22 | |
15,348 | +19,53 | |
1,6500 | +17,86 | |
0,8200 | +15,49 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,2700 | -19,62 | |
5,2300 | -20,64 | |
2,0150 | -21,29 | |
0,7800 | -29,73 | |
2.849,50 | -83,34 |
Beitrag zu dieser Diskussion schreiben
Ergomed in strong position after storming performance in 2020
https://www.proactiveinvestors.co.uk/companies/news/944610/e…
https://www.proactiveinvestors.co.uk/companies/news/944610/e…
Ergomed highlight 'year of strong delivery' both financially and strategically
https://www.proactiveinvestors.co.uk/companies/news/944589/e…
https://www.proactiveinvestors.co.uk/companies/news/944589/e…
releasing the results for the Full Year of 2020. We will be hosting a presentation for analysts and investors at 9am GMT.
Visit the investor site to access the presentation, which will be uploaded today.
https://www.ergomedplc.com/investor-relations/reports-and-pr…
Visit the investor site to access the presentation, which will be uploaded today.
https://www.ergomedplc.com/investor-relations/reports-and-pr…
Pharmadienstleistungen boomen..... so auch die Dienstleistungen von ERGOMED!
Am 23.3.2021 publizert ERGOMED Ergbenisse für 2020!
https://www.marketscreener.com/quote/stock/ERGOMED-PLC-16917…
https://www.marketscreener.com/quote/stock/ERGOMED-PLC-16917…
Webinar: "Early Involvement of Patients in Pharmaceutical Research and Development for Rare Diseases", this free webinar will occur on 16 March 2021.
In this webinar, our orphan rare disease experts Inês Alves and Alex A. will share valuable insights on how research processes can be conducted with early patient involvement, focusing on patients' priorities and the challenges that exist across these processes.
This webinar will run in 2 sessions:
• Session 1: 10am EDT / 2pm GMT / 3pm CET
• Session 2: 2pm EDT / 6pm GMT / 7pm CET
To register for one of these sessions, please click directly on: https://lnkd.in/eJXexn8
For more information, please visit our website: https://lnkd.in/egjBwi3
In this webinar, our orphan rare disease experts Inês Alves and Alex A. will share valuable insights on how research processes can be conducted with early patient involvement, focusing on patients' priorities and the challenges that exist across these processes.
This webinar will run in 2 sessions:
• Session 1: 10am EDT / 2pm GMT / 3pm CET
• Session 2: 2pm EDT / 6pm GMT / 7pm CET
To register for one of these sessions, please click directly on: https://lnkd.in/eJXexn8
For more information, please visit our website: https://lnkd.in/egjBwi3
Mal sehen, wen Ergomed als nächstes aufkauft
Rare Disease Day 2021 | Ergomed plc
... das nächste Ziel 18 Euro.
... und es geht weiter.
Ergomed Aktie kaufenswert?